Related Experiment Video
Updated: Jul 9, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Targeting genes in the renin-angiotensin system
1Division of Nephrology and Department of Medicine, Duke University and Durham VA Medical Centers, Durham, North Carolina 27710, USA.
Current Opinion in Nephrology and Hypertension
|December 20, 2007
Summary
Gene targeting advances offer new insights into the renin-angiotensin system
Area of Science:
- Physiology
- Genetics
- Cardiovascular Medicine
Background:
- The renin-angiotensin system (RAS) is crucial for blood pressure regulation and fluid balance.
- Dysregulation of the RAS is linked to hypertension and cardiovascular diseases.
- Understanding RAS physiology is vital for managing these conditions.
Purpose of the Study:
- To review studies utilizing gene targeting to explore RAS physiology.
- To uncover novel perspectives on the complex biology of the RAS.
- To elucidate the mechanisms of action for RAS-targeting drugs.
Main Methods:
- Gene targeting via homologous recombination in embryonic stem cells.
- Genomic manipulation in animal models.
- Analysis of classical and novel RAS component functions.
Main Results:
- Gene targeting has provided unique insights into RAS biology over the past decade.
- Clarified functions of newly discovered angiotensin-converting enzyme homologues.
- Advanced understanding of classical RAS component functions.
Conclusions:
- Gene targeting experiments clarify mechanisms of action for pharmacological RAS antagonists.
- Findings may guide improved therapeutic strategies for hypertension and kidney diseases.
- Highlights the utility of genetic approaches in cardiovascular research.
Related Concept Videos
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: